A Reinforcement Approach to Improve Diabetes Management
Launched by YALE UNIVERSITY · Jun 16, 2014
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age 12-21 years old;
- • 2. diagnosis of type 1 diabetes (T1D) \>12 months via ADA guidelines
- • 3. receiving diabetes treatment at Yale Pediatric Diabetes Clinic and not meeting clinical care guidelines
- • 4. SMBG user with clinical recommendations to test \>4 times/day and using a device that allows for remote uploading (e.g., Aviva, Contour, Freestyle, Lifescan, etc.; equipment for uploading will be provided);
- • 5. access to a computer with internet for uploading and sending SMBG data;
- • 6. access to a cell phone with text messaging capabilities and willing to text after SMBG testing and receive messages about reinforcement;
- • 7. English speaking, able to read at \>5th grade level, and pass an informed consent quiz; and adequate knowledge of insulin dosing and dietary recommendations for managing T1D.
- Exclusion Criteria:
- • 1. have a major psychiatric or neurocognitive disorder (e.g., severe learning impairment) that would inhibit participation;
- • 2. have a major visual impairment;
- • 3. have a significant other medical condition that impacts diabetes management (e.g., asthma, rheumatoid arthritis, or other condition that requires steroid treatment);
- • 4. plan to switch insulin delivery mode (injection to pump or vice versa) in the next 12 months, or have recently switched;
- • 5. are participating in another clinical trial.
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
William Tamborlane, MD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials